This last week we presented our project at CES 2019 in Las Vegas, one of the most important electronic congresses in the world. This has been thanks to the European American Enterprise Council, which has chosen us as a project with the potential to be implemented in the United States.
During these days, we have learned from new digital health projects that are coming up. In MJN we believe that technology must be at the service of people and it is in this same direction that we put all our efforts to improve the quality of life of people with epilepsy.
At the same time, we have had the opportunity to present our project to different investors and partners who will be able to help us in the near future so that our MJN-SERAS device to assess the risk of epileptic seizures can become a reality in the United States.
“We’ve had the opportunity
present our project to
different investors and partners”
One of the most important challenges is obtaining certification from the American Drug Agency, FDA, and that’s where private equity support can help us obtain FDA permits.
It should be noted that within the events organized by EAEC, the Silicon Valley Funding Summit, we won first prize in the startup competition. Forty projects from all over the world took part in the contest. We are proud that we can talk about epilepsy in all these forums and that we are also recognized as an outstanding project at the international level.
Finally, we would like to thank Acció and her representative here at the CES, Alba Quer, for their invaluable help in the day-to-day running of the congress.
